Formulation of liquid dosage form with the isolated citric acid from suha (citrus maxima) : (Record no. 100674)

MARC details
000 -LEADER
fixed length control field 02511nam a22002657a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20261104144253.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 261104s2025 |||||||| |||| 00| 0 eng d
050 ## - LIBRARY OF CONGRESS CALL NUMBER
Classification number T PHAR
Item number F67 2025
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Banting, Eunice
245 10 - TITLE STATEMENT
Title Formulation of liquid dosage form with the isolated citric acid from suha (citrus maxima) :
Remainder of title basis for stability studies /
Statement of responsibility, etc. Eunice Banting, Sofia Julia Cortez, Chrislyn Ann Joy Gloton, Richbern Sayson, and Adelyne Tud.
264 ## - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture EAC Cavite :
Name of producer, publisher, distributor, manufacturer School of Pharmacy,
Date of production, publication, distribution, manufacture, or copyright notice 2025.
300 ## - PHYSICAL DESCRIPTION
Extent vii, 95 pages ;
Dimensions 28 cm.
336 ## - CONTENT TYPE
Source rdacontent
Content type term text
337 ## - MEDIA TYPE
Source rdamedia
Media type term unmediated
338 ## - CARRIER TYPE
Source rdacarrier
Carrier type term volume
500 ## - GENERAL NOTE
General note Experimental research
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references
520 ## - SUMMARY, ETC.
Summary, etc. Citrus maxima is known to contain different bioactive chemical constituents, among which is citric acid, used in the pharmaceutical industry and recognized for its antioxidant qualities. The citric acid present in the Citrus maxima has limited research in regard to the incorporation of the citric acid in a liquid dosage form. The purpose of the study is to formulate a physically stable liquid dosage form with the use of citric acid isolated from the fruit Citrus maxima. The juice from the pulp of the fruit, from which the citric acid was isolated, reveals a 19.76% yield of citric acid. The suha juice was diluted (distilled water) and neutralized (NaOH) with a 7.00 to 7.20 pH level. The sample underwent various heating processes to crystallize. FTIR analysis indicated the presence of citric acid, and impurity tests showed moisture content (32.71% to 37.70%). Concentration from titration of citric acid (0.031 to 0.040 M). The stability of the liquid dosage form incorporated with the isolated citric acid revealed an acidic pH, stable temperature, and physical properties. The thin chromatography analysis using solvent (distilled water, acetic acid, and butanol) for the detection of citric acid and identification of RF value (0.95 to 0.98), revealing the presence of citric acid. The pH (4.05-4.18) of the formulation at various temperatures for one month shows its stability over an extended period. In conclusion, the citric acid isolated from the Citrus maxima fruit helps stabilize the formulated liquid dosage.
700 1# - ADDED ENTRY--PERSONAL NAME
Relator code author
Personal name Cortez, Sofia Julia
700 1# - ADDED ENTRY--PERSONAL NAME
Relator code author
Personal name Gloton, Chrislyn Ann Joy
700 1# - ADDED ENTRY--PERSONAL NAME
Relator code author
Personal name Sayson, Richbern
700 1# - ADDED ENTRY--PERSONAL NAME
Relator code author
Personal name Tud, Adelyne
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type THESIS
Call number prefix EAC Cavite-Thesis Section
Suppress in OPAC No
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    Library of Congress Classification     EAC Library Cavite EAC Library Cavite EAC Cavite-Thesis Section 11/04/2026   T PHAR F67 2025 ML-TH2851 11/04/2026 11/04/2026 THESIS